Daniel Mattle

Daniel Mattle, PhD, MBA currently serves as the Business Unit Head Pharma Solutions at KLK Kolb. Prior to this, Daniel held various roles at Rentschler Biopharma SE, Stiftung KOSTA, Swiss Armed Forces, Celonic AG, Roche, and Stiftung KOSTA. Daniel holds a PhD in Molecular Biology from Aarhus University and has completed multiple executive MBA programs from various prestigious institutions.